全球静脉治疗与静脉通路市场

到 2030 年，全球静脉注射和静脉通路市场规模将达到 316 亿美元

全球静脉治疗和静脉通路市场规模预计在2024年为261亿美元，到2030年将达到316亿美元，2024年至2030年的复合年增长率为3.2%。药物管理应用是本报告分析的细分市场之一，预计其复合年增长率为2.5%，到分析期结束时规模将达到122亿美元。血液製品应用细分市场在分析期间的复合年增长率预计为4.2%。

美国市场规模估计为 71 亿美元，中国市场预期复合年增长率为 5.9%

美国静脉治疗和静脉通路市场规模预计在2024年达到71亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到62亿美元，在2024-2030年的分析期间内，复合年增长率为5.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.3%和2.5%。在欧洲，预计德国市场的复合年增长率为1.8%。

全球静脉治疗和静脉通路市场—主要趋势和驱动因素摘要

为什么静脉治疗和静脉通路对现代医学至关重要？

静脉治疗和静脉通路是现代医疗保健的基础，能够快速有效地将液体、药物、营养物质和血液製品直接输送到血液中。这种给药方式可提供即时的生物利用度，使其成为重症加护、急诊医学、外科手术和慢性病管理的关键。从抗生素和化疗到补液和纠正电解质失衡，静脉 (IV) 治疗的多功能性使其应用范围广泛。在医院，它通常用作急性疾病和创伤的治疗方法；而在门诊和居家医疗中，它支持癌症、自体免疫疾病和需要长期抗生素治疗的感染疾病等疾病的长期治疗。静脉通路对于抽血、诊断和治疗性血液分离术至关重要，使其成为预防性和治疗性医疗保健的必要条件。糖尿病、心血管疾病和肾衰竭等生活方式相关慢性疾病的盛行率日益上升，显着增加了对可靠血管通路和持续静脉治疗的需求。在儿科和老年族群中，专用静脉通路装置可提高病患的安全性和舒适度，同时减少手术併发症。随着医疗保健系统越来越注重效率和疗效，静脉治疗已成为重要的临床工具，支撑着各级医疗机构的紧急介入和结构化治疗途径。

科技创新如何提高静脉通路和液体治疗的安全性和准确性？

技术进步正在彻底改变静脉治疗和静脉通路，提高准确性，最大限度地减少併发症，并实现患者友善操作。最显着的进展之一是超音波引导下置管的应用，这显着提高了首次成功率，尤其对于静脉通路困难的患者。使用红外线和近红外线成像的静脉可视化设备使临床医生无需反覆穿刺即可找到最佳静脉，从而减少不适和感染风险。配备给药错误减少软体和条码扫描的智慧型输液帮浦正在成为医院的标准配置，有助于防止用药错误并确保准确的流速。导管材料正在不断发展，包括抗菌涂层和生物相容性聚合物，可降低血栓症和导管相关血流感染的风险。中央静脉导管、周边置入中央静脉导管(PICC) 和中线导管现已有多种配置可供选择，以满足不同治疗方法和疗程的特殊要求。无针连接器和闭式系统传输装置也降低了针刺伤和污染的风险。同时，穿戴式输液设备使门诊和居家输液治疗成为可能，为患者带来更大的灵活性和舒适度。与电子健康记录的整合可以持续监测和记录输液参数，支持循证决策并改善临床疗效。这些技术创新正在重塑静脉治疗，提高其安全性、准确性以及对不同患者群体的可及性。

临床环境和病患状况如何影响静脉通路装置的选择？

静脉通路设备和输液策略的选择与临床环境、治疗时间长度和患者的个别特征密切相关。在急诊室和加护病房，通常会快速放置週边静脉通路以输送液体和药物，而中心静脉通路则考虑用于更复杂或长期的治疗。外科患者可能需要短期通路进行麻醉和术后恢復，肿瘤患者可以从植入式输液港和 PICC 通路中受益，以便在最大程度上减少不适的情况下重复化疗输液。新生儿和儿科患者的静脉细小且敏感，需要专门的微导管和减轻疼痛的技术。患有需要频繁或持续输液的慢性疾病患者（例如患有囊肿纤维化或免疫力缺乏的患者）优先考虑耐用、低维护的设备。患者的合併症也会影响设备的选择，对于感染和血栓症形成风险高的患者，需要使用抗菌和肝素黏合导管。家庭医疗保健机构需要使用者友善的携带式解决方案，以支援患者独立生活并确保临床监测。在资源匮乏的环境中，由于缺乏熟练的人员和设备，可能需要使用更简单、更低成本的方案，但全球范围内正在努力标准化通讯协定并培训医疗保健专业人员。临床应用和患者需求的多样性持续推动产品创新以及插入和维护通讯协定的改进，凸显了在各种静脉治疗中客製化静脉通路解决方案的复杂性和重要性。

推动全球静脉治疗和静脉通路市场成长的因素是什么？

静脉治疗和静脉通路市场的成长受到多种因素的推动，包括人口结构变化、疾病负担加重、医疗保健现代化以及医疗设备的持续进步。其中一个关键驱动因素是全球慢性病和感染疾病的增多，例如癌症、败血症和自体免疫疾病，这些疾病需要长期强化静脉治疗。人口老化，尤其是在已开发国家，也加剧了需求的增长，因为老年人通常需要更频繁的住院和复杂的药物。门诊和居家医疗服务的扩展推动了对可携式、患者友善输液技术的需求，这些技术可以在医院外安全使用。导管设计、药物传输系统和输液监测的技术进步，正在鼓励更多临床医师采用先进、安全的输液解决方案。此外，全球为减少医院内感染所做的努力，正在推动封闭系统设备和抗菌材料的广泛应用。在新兴国家，对医疗保健基础设施的投资不断增加，以及对静脉治疗最佳实践的认识不断提高，正在开拓新的市场，并扩大先进静脉通路技术的可及性。此外，培训计画和认证标准正在提升医疗专业人员的技术水准，减少操作失误，并改善患者的治疗效果。此外，新型生技药品和静脉注射药物的监管核准也正在扩大依赖可靠液体输送的治疗方法。随着全球医疗保健系统持续优先考虑成本效益、安全性和以患者为中心的护理，静脉治疗和静脉通路市场在医院和非医院环境中都有望持续成长。

部分

用途（药物用途、血液製品用途、营养物/缓衝液用途、扩容剂用途）、最终用途（医院最终用途、诊所最终用途、门诊手术中心最终用途）

受访公司范例

• Ajinomoto Health & Nutrition North America, Inc.
• AngioDynamics, Inc.
• B. Braun Medical Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Company（BD）
• Cardinal Health
• Core IV Therapy, LLC
• Cryojuvenate UK Ltd.
• CSL Vifor
• Drip Hydration
• Fresenius Kabi
• Haemonetics Corporation
• ICU Medical, Inc.
• Medtronic plc
• Otsuka Pharmaceutical Co., Ltd.
• Polymedicure
• Smiths Medical, Inc.
• Teleflex Incorporated
• Terumo Corporation
• Vygon SAS
• Vetter Pharma-Fertigung GmbH & Co. KG

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Intravenous Therapy and Vein Access Market to Reach US$31.6 Billion by 2030

The global market for Intravenous Therapy and Vein Access estimated at US$26.1 Billion in the year 2024, is expected to reach US$31.6 Billion by 2030, growing at a CAGR of 3.2% over the analysis period 2024-2030. Medication Administration Application, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$12.2 Billion by the end of the analysis period. Growth in the Blood-based Products Application segment is estimated at 4.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.1 Billion While China is Forecast to Grow at 5.9% CAGR

The Intravenous Therapy and Vein Access market in the U.S. is estimated at US$7.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 5.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.8% CAGR.

Global Intravenous Therapy and Vein Access Market - Key Trends & Drivers Summarized

Why Is Intravenous Therapy and Vein Access a Cornerstone of Modern Clinical Care?

Intravenous therapy and vein access have become fundamental to contemporary healthcare, enabling rapid and efficient administration of fluids, medications, nutrients, and blood products directly into the bloodstream. This mode of delivery offers immediate bioavailability, making it indispensable for critical care, emergency medicine, surgery, and chronic disease management. The versatility of intravenous (IV) therapy supports a wide range of applications, from administering antibiotics and chemotherapy to maintaining hydration and correcting electrolyte imbalances. In hospitals, it is often the first line of intervention for acute illnesses and trauma, while in outpatient and home care settings, it supports long-term treatments for conditions such as cancer, autoimmune diseases, and infections requiring prolonged antimicrobial therapy. Vein access is essential for drawing blood, delivering diagnostics, and performing therapeutic apheresis, making it integral to both preventive and curative care. The growing prevalence of lifestyle-related chronic illnesses, such as diabetes, cardiovascular disease, and kidney failure, has significantly increased the need for reliable vascular access and ongoing IV treatment. In pediatric and geriatric populations, specialized vein access devices improve patient safety and comfort while reducing procedural complications. With healthcare systems increasingly emphasizing efficiency and outcomes, intravenous therapy has established itself as a critical clinical tool, underpinning both emergency interventions and structured treatment pathways across all levels of care.

How Are Innovations Improving the Safety and Precision of Vein Access and Infusion Therapy?

Technological advances are revolutionizing intravenous therapy and vein access by enhancing precision, minimizing complications, and making procedures more patient-friendly. One of the most notable developments is the use of ultrasound-guided insertion techniques, which have dramatically improved first-attempt success rates, especially in patients with difficult venous access. Vein visualization devices using infrared light and near-infrared imaging allow clinicians to identify optimal veins without repeated punctures, reducing discomfort and risk of infection. Smart infusion pumps equipped with dose error reduction software and barcode scanning are becoming standard in hospitals, helping to prevent medication errors and ensure accurate flow rates. Catheter materials have evolved to include antimicrobial coatings and biocompatible polymers that lower the risk of thrombosis and catheter-associated bloodstream infections. Central venous catheters, peripherally inserted central catheters (PICCs), and midline catheters are now available in multiple configurations to meet the specific requirements of different therapies and durations. Needle-free connectors and closed-system transfer devices are also reducing the risk of needle-stick injuries and contamination. Meanwhile, wearable infusion devices are enabling ambulatory and home-based IV therapy, giving patients greater flexibility and comfort. Integration with electronic medical records allows for continuous monitoring and documentation of infusion parameters, supporting evidence-based decision-making and better clinical outcomes. These innovations are collectively reshaping the administration of intravenous therapy by making it safer, more accurate, and more accessible across diverse patient populations.

How Do Clinical Settings and Patient Profiles Influence the Selection of IV Access Devices?

The choice of intravenous access devices and infusion strategies is closely aligned with the clinical setting, duration of therapy, and individual patient characteristics. In emergency rooms and intensive care units, peripheral IV lines are often placed quickly for immediate fluid and drug delivery, with central venous access considered for more complex or long-term treatments. Surgical patients may require short-term access for anesthesia and postoperative recovery, while oncology patients benefit from implantable ports or PICC lines to facilitate repetitive chemotherapy infusions with minimal discomfort. Neonates and pediatric patients present unique challenges due to smaller vein size and increased sensitivity, leading to the use of specialized microcatheters and pain-reduction techniques. For patients with chronic conditions requiring frequent or continuous infusions, such as those with cystic fibrosis or immune deficiencies, durable and low-maintenance devices are prioritized. Patient comorbidities also affect device selection, with those at high risk of infection or thrombosis requiring antimicrobial or heparin-bonded catheters. Home healthcare settings demand user-friendly and portable solutions that support patient independence while ensuring clinical oversight. In resource-limited settings, the availability of skilled personnel and equipment may dictate the use of simpler, lower-cost options, although efforts are being made globally to standardize protocols and train healthcare workers in advanced techniques. The diversity in clinical applications and patient needs continues to drive product innovation and the refinement of insertion and maintenance protocols, underscoring the complexity and importance of tailored vein access solutions within the broader spectrum of intravenous therapy.

What Is Driving the Expansion of the Global Intravenous Therapy and Vein Access Market?

The growth in the intravenous therapy and vein access market is driven by multiple factors rooted in demographic shifts, rising disease burden, healthcare modernization, and ongoing advancements in medical devices. One of the primary drivers is the global increase in chronic and infectious diseases that require prolonged or intensive intravenous treatment, such as cancer, sepsis, and autoimmune disorders. The aging population, particularly in developed countries, is also contributing to increased demand, as older adults often require more frequent hospitalizations and complex medication regimens. The expansion of outpatient and home-based care services is fostering the need for portable and patient-friendly infusion technologies that can be used safely outside hospital settings. Technological improvements in catheter design, drug delivery systems, and infusion monitoring are encouraging more clinicians to adopt sophisticated and safer IV solutions. Additionally, global efforts to reduce hospital-acquired infections are leading to widespread adoption of closed-system devices and antimicrobial materials. In emerging economies, growing investment in healthcare infrastructure and rising awareness of best practices in IV therapy are opening new markets and expanding access to advanced vein access techniques. Training programs and certification standards are also improving practitioner skill levels, reducing procedural errors, and boosting patient outcomes. Furthermore, regulatory approvals for new biologics and intravenous medications are creating a larger pool of therapies that depend on reliable infusion delivery. As healthcare systems worldwide continue to emphasize cost-effectiveness, safety, and patient-centered care, the market for intravenous therapy and vein access is poised for sustained growth across both hospital and non-hospital settings.

SCOPE OF STUDY:

The report analyzes the Intravenous Therapy and Vein Access market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application, Volume Expander Application); End-Use (Hospitals End-Use, Clinics End-Use, Ambulatory Surgery Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Ajinomoto Health & Nutrition North America, Inc.
• AngioDynamics, Inc.
• B. Braun Medical Inc.
• B. Braun Melsungen AG
• Baxter International Inc.
• Becton, Dickinson and Company (BD)
• Cardinal Health
• Core IV Therapy, LLC
• Cryojuvenate UK Ltd.
• CSL Vifor
• Drip Hydration
• Fresenius Kabi
• Haemonetics Corporation
• ICU Medical, Inc.
• Medtronic plc
• Otsuka Pharmaceutical Co., Ltd.
• Polymedicure
• Smiths Medical, Inc.
• Teleflex Incorporated
• Terumo Corporation
• Vygon SAS
• Vetter Pharma-Fertigung GmbH & Co. KG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Intravenous Therapy and Vein Access - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Hospitalization Rates and Chronic Disease Burden Throw the Spotlight on Intravenous Therapy and Vein Access as Clinical Cornerstones
  • Growth in Chemotherapy, Parenteral Nutrition, and Critical Care Propels Demand for Advanced IV Access Devices
  • Here's the Story: Increasing Preference for Minimally Invasive, Long-Dwell Access Strengthens the Business Case for PICCs and Midlines
  • Expansion of Home Infusion Therapy and Outpatient Care Models Drives Demand for User-Friendly, Low-Complication Access Systems
  • Here's How Ultrasound-Guided and Image-Assisted Techniques Are Enhancing First-Attempt Success and Reducing Complications
  • Growing Focus on Infection Prevention and Line-Associated Risks Fuels Innovation in Antimicrobial Catheters and Flush Systems
  • Here's How Needle-Free Connectors and Closed-System Devices Are Improving Safety for Both Patients and Clinicians
  • Aging Population and Rising Surgical Volumes Expand Use of Peripheral and Central Venous Access Devices Across Specialties
  • Technological Advancements in Securement, Dressing, and Stabilization Improve Device Dwell Time and Reduce Dislodgement
  • Growth in Biologic and Specialty Drug Infusion Therapies Spurs Demand for High-Pressure and Power Injectable Access Devices
  • Here's How Real-Time Monitoring and Smart Infusion Systems Are Optimizing Dosing Accuracy and Therapy Compliance
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Intravenous Therapy and Vein Access Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Intravenous Therapy and Vein Access by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Medication Administration Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Medication Administration Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Medication Administration Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Blood-based Products Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Blood-based Products Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Blood-based Products Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Nutrition & Buffer Solution Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Nutrition & Buffer Solution Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Nutrition & Buffer Solution Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Volume Expander Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Volume Expander Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Volume Expander Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 29: USA Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 32: Canada Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Canada Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: Canada 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• JAPAN
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 38: Japan Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: Japan Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: Japan 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 41: Japan Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Japan Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: Japan 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• CHINA
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 44: China Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: China Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: China 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 47: China Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: China Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: China 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• EUROPE
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 50: Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 51: Europe Historic Review for Intravenous Therapy and Vein Access by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Europe 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Europe Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Europe 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• FRANCE
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 59: France Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: France Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: France 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 62: France Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: France Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: France 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• GERMANY
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 65: Germany Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Germany Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Germany 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Germany Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Germany 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 71: Italy Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Italy Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Italy 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Italy Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Italy 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 77: UK Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: UK Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: UK 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 80: UK Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: UK Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: UK 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 83: Spain Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Spain Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Spain 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 86: Spain Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Spain Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: Spain 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 89: Russia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Russia Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: Russia 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 92: Russia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Russia Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Russia 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Rest of Europe Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Rest of Europe 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Rest of Europe Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Rest of Europe 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 102: Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 110: Australia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Australia Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Australia 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 113: Australia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Australia Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: Australia 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• INDIA
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 116: India Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: India Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: India 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 119: India Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: India Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: India 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 122: South Korea Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: South Korea Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: South Korea 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 125: South Korea Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: South Korea Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: South Korea 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Rest of Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Rest of Asia-Pacific Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 134: Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 135: Latin America Historic Review for Intravenous Therapy and Vein Access by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 137: Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Latin America Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 140: Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Latin America Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 143: Argentina Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Argentina Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Argentina 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 146: Argentina Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Argentina Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Argentina 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 149: Brazil Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Brazil Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Brazil 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 152: Brazil Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Brazil Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Brazil 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 155: Mexico Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Mexico Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Mexico 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 158: Mexico Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Mexico Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Mexico 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Rest of Latin America Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Rest of Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Rest of Latin America Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Rest of Latin America 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 167: Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 168: Middle East Historic Review for Intravenous Therapy and Vein Access by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 170: Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Middle East Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 173: Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Middle East Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 176: Iran Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Iran Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Iran 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 179: Iran Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Iran Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Iran 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 182: Israel Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Israel Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Israel 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 185: Israel Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Israel Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Israel 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Saudi Arabia Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Saudi Arabia 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Saudi Arabia Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Saudi Arabia 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 194: UAE Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: UAE Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: UAE 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 197: UAE Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: UAE Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: UAE 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Middle East Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Rest of Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Middle East Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Rest of Middle East 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030
• AFRICA
  • Intravenous Therapy and Vein Access Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 206: Africa Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Africa Historic Review for Intravenous Therapy and Vein Access by Application - Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Africa 16-Year Perspective for Intravenous Therapy and Vein Access by Application - Percentage Breakdown of Value Sales for Medication Administration Application, Blood-based Products Application, Nutrition & Buffer Solution Application and Volume Expander Application for the Years 2014, 2025 & 2030
  • TABLE 209: Africa Recent Past, Current & Future Analysis for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Africa Historic Review for Intravenous Therapy and Vein Access by End-Use - Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Africa 16-Year Perspective for Intravenous Therapy and Vein Access by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Clinics End-Use and Ambulatory Surgery Centers End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION